T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.29% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.32% |
| 4 | Consumer Discretionary | 14.01% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1501
DELISTED
Abiomed Inc
ABMD
| $2.88M | ﹤0.01% |
15,350
-9,744
| -39% | -$1.82M |
|
1502
Starwood Property Trust
STWD
$6.12B
| $2.87M | ﹤0.01% |
134,349
+15,020
| +13% | +$325K |
|
1503
NNN REIT
NNN
$8.87B
| $2.83M | ﹤0.01% |
65,664
+80
| +0.1% | +$3.36K |
|
1504
The GEO Group
GEO
$4.01B
| $2.83M | ﹤0.01% |
119,941
+48,070
| +67% | +$1.22M |
|
1505
Diodes
DIOD
$4.7B
| $2.82M | ﹤0.01% |
98,508
-8,712
| -8% | -$271K |
|
|
EGN
1506
DELISTED
Energen
EGN
| $2.8M | ﹤0.01% |
48,646
-9,017
| -16% | -$490K |
|
|
SVC
1507
Service Properties Trust
SVC
$1.07B
| $2.8M | ﹤0.01% |
18,732
+1,792
| +11% | +$263K |
|
1508
Upland Software
UPLD
$17.3M
| $2.78M | ﹤0.01% |
+12,817
| New | +$2.81M |
|
1509
National Healthcare
NHC
$3.49B
| $2.77M | ﹤0.01% |
45,532
-146,798
| -76% | -$9.37M |
|
|
DO
1510
DELISTED
Diamond Offshore Drilling
DO
| $2.74M | ﹤0.01% |
147,250
-4,348,634
| -97% | -$70.7M |
|
1511
Huntsman Corp
HUN
$1.82B
| $2.74M | ﹤0.01% |
82,182
+4,760
| +6% | +$146K |
|
1512
The Greenbrier Companies
GBX
$1.43B
| $2.72M | ﹤0.01% |
51,066
-10
| -0% | -$502 |
|
|
FDC
1513
DELISTED
First Data Corporation
FDC
| $2.72M | ﹤0.01% |
162,630
+60,820
| +60% | +$1.05M |
|
1514
Crown Holdings
CCK
$12.9B
| $2.71M | ﹤0.01% |
48,242
-10,399
| -18% | -$615K |
|
1515
Senseonics Holdings Inc
SENS
$408M
| $2.71M | ﹤0.01% |
50,873
+14,431
| +40% | +$802K |
|
1516
Universal Display
OLED
$4.13B
| $2.66M | ﹤0.01% |
15,417
-1,981
| -11% | -$316K |
|
1517
Sunrun
RUN
$2.5B
| $2.65M | ﹤0.01% |
448,552
+332,409
| +286% | +$1.91M |
|
|
AMAG
1518
DELISTED
AMAG Pharmaceuticals
AMAG
| $2.63M | ﹤0.01% |
198,159
+1,573
| +0.8% | +$23.7K |
|
1519
CNO Financial Group
CNO
$5.09B
| $2.62M | ﹤0.01% |
105,958
+790
| +0.8% | +$19.3K |
|
1520
iShare MSCI Eurozone ETF
EZU
$9.97B
| $2.61M | ﹤0.01% |
60,100
+27,600
| +85% | +$1.2M |
|
|
FLG
1521
Flagstar Bank National Association
FLG
$5.95B
| $2.61M | ﹤0.01% |
66,713
-27,775
| -29% | -$1.07M |
|
1522
HNI Corp
HNI
$3.56B
| $2.6M | ﹤0.01% |
67,437
-6,770
| -9% | -$248K |
|
1523
Novartis
NVS
$285B
| $2.6M | ﹤0.01% |
34,555
+12,125
| +54% | +$915K |
|
1524
CarParts.com
PRTS
$48.4M
| $2.59M | ﹤0.01% |
102,771
-11,312
| -10% | -$281K |
|
1525
Trinity Industries
TRN
$2.35B
| $2.59M | ﹤0.01% |
96,037
-11,431
| -11% | -$285K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.